Accel Wealth Management Abb Vie Inc. Transaction History
Accel Wealth Management
- $268 Million
- Q1 2025
A detailed history of Accel Wealth Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Accel Wealth Management holds 5,173 shares of ABBV stock, worth $926,484. This represents 0.4% of its overall portfolio holdings.
Number of Shares
5,173
Previous 5,214
0.79%
Holding current value
$926,484
Previous $926,000
16.95%
% of portfolio
0.4%
Previous 0.36%
Shares
18 transactions
Others Institutions Holding ABBV
# of Institutions
4,129Shares Held
1.29BCall Options Held
17MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA173MShares$31 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$24.4 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$14.3 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$9.27 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$7.11 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $317B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...